GoodRx Expands Access to Eli Lilly and Companys New Oral GLP-1, Foundayo, and Zepbound KwikPen with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access to the newly FDA-approved oral GLP-1 medication, Foundayo (orforglipron). Eligible self-pay patients can access Foundayo through GoodRx at...